Toxicity, biodistribution, and ex vivo MRI detection of intravenously injected cationized ferritin

The goal of the work was to establish the toxicity and biodistribution of the superparamagnetic protein cationized ferritin (CF) after intravenous injection. Intravenously injected CF has been used to target the extracellular matrix with high specificity in the kidney glomerulus, allowing measurements of individual glomeruli using T  2* ‐weighted MRI. For the routine use of CF as an extracellular matrix‐specific tracer, it is important to determine whether CF is toxic. In this work, we investigated the renal and hepatic toxicity, leukocyte count, and clearance of intravenously injected CF. Furthermore, we studied CF labeling in several organs using MRI and immunohistochemistry. Serum measurements of biomarkers suggest that intravenous injection of CF is neither nephrotoxic nor hepatotoxic and does not increase leukocyte counts in healthy rats at a dose of 5.75 mg/100 g. In addition to known glomerular labeling, confocal and MRI suggest that intravenously injected CF labels the extracellular matrix of the hepatic sinusoid, extracellular glycocalyx of alveolar endothelial cells, and macrophages in the spleen. Liver T  2* values suggest that CF is cleared by 7 days after injection. These results suggest that CF may serve as a useful contrast agent for detection of a number of structures and functions with minimal toxicity. Magn Reson Med, 2013. © 2012 Wiley Periodicals, Inc.

[1]  D. Mischoulon,et al.  Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors , 1994, Molecular and cellular biology.

[2]  J. Sanes.  Roles of extracellular matrix in neural development. , 1983, Annual review of physiology.

[3]  B. Brenner,et al.  Glomeruli and blood pressure. Less of one, more the other? , 1988, American journal of hypertension.

[4]  Elizabeth Jones,et al.  Living in three dimensions , 2007, Cell Biochemistry and Biophysics.

[5]  S. Mann,et al.  Magnetoferritin: in vitro synthesis of a novel magnetic protein. , 1992, Science.

[6]  J. Frank,et al.  Initial assessment of magnetoferritin biokinetics and proton relaxation enhancement in rats. , 1995, Academic radiology.

[7]  J A Frank,et al.  Magnetoferritin: Characterization of a novel superparamagnetic MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.

[8]  K. Bennett,et al.  Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging , 2010, Magnetic resonance in medicine.

[9]  P. Arosio,et al.  Production and characterization of recombinant heteropolymers of human ferritin H and L chains. , 1993, The Journal of biological chemistry.

[10]  F M Watt,et al.  Regulation of development and differentiation by the extracellular matrix. , 1993, Development.

[11]  J. Brody,et al.  Binding of Charged Ferritin to Alveolar Wall Components and Charge Selectivity of Macromolecular Transport in Permeability Pulmonary Edema in Rats , 1984, Circulation research.

[12]  Teresa Wu,et al.  Measuring glomerular number and size in perfused kidneys using MRI. , 2011, American journal of physiology. Renal physiology.

[13]  P. Tsao,et al.  A human ferritin iron oxide nano‐composite magnetic resonance contrast agent , 2008, Magnetic resonance in medicine.

[14]  L. Goldstein,et al.  Use of cationized ferritin as a label of negative charges on cell surfaces. , 1972, Journal of ultrastructure research.

[15]  R. Dermietzel,et al.  Surface charges associated with fenestrated brain capillaries. II. In vivo studies on the role of molecular charge in endothelial permeability. , 1983, Journal of ultrastructure research.

[16]  Mitsuru Nenoi,et al.  Regulation of , 2004 .

[17]  D. Leslie-Pelecky,et al.  Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. , 2008, Molecular pharmaceutics.

[18]  N. Simionescu,et al.  Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites , 1981, The Journal of cell biology.

[19]  S. Iskandar,et al.  Nephropathy induced in a nephritis-resistant inbred mouse strain with the use of a cationized antigen. , 1986, The American journal of pathology.

[20]  M. Young,et al.  Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. , 2006, Journal of the American Chemical Society.

[21]  M. Sasaki,et al.  Cationic macromolecule-induced nephrotic syndrome in rabbits. Lack of immune complex involvement. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[22]  J. Schmidley,et al.  Anionic sites on the luminal surface of fenestrated and continuous capillaries of the CNS , 1986, Brain Research.

[23]  J. Jones,et al.  Solute permeability of the alveolar capillary barrier. , 1987, Thorax.

[24]  Ivo Wolf,et al.  Quantification of glomerular number and size distribution in normal rat kidneys using magnetic resonance imaging. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  D. Kondziella,et al.  A ferritin tracer study of compensatory spinal CSF outflow pathways in kaolin-induced hydrocephalus , 2007, Acta Neuropathologica.

[26]  Z. Werb,et al.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Tompkins,et al.  Effect of molecular charge on choroid-plexus permeability: Tracer studies with cationized ferritins , 2004, Cell and Tissue Research.

[28]  A. Koretsky,et al.  MRI of the basement membrane using charged nanoparticles as contrast agents , 2008, Magnetic resonance in medicine.

[29]  V. Paradis,et al.  Liver extracellular matrix in health and disease , 2003, The Journal of pathology.

[30]  Z. Fuks,et al.  Differential structural requirements for the induction of cell attachment, proliferation and differentiation by the extracellular matrix. , 1985, Experimental cell research.

[31]  M. Hughson,et al.  Nephron number, glomerular volume, renal disease and hypertension , 2008, Current opinion in nephrology and hypertension.

[32]  J. Sanes,et al.  Extracellular matrix molecules that influence neural development. , 1989, Annual review of neuroscience.

[33]  R. Stahl,et al.  Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  J. Frank,et al.  Magnetoferritin. Biomineralization as a novel molecular approach in the design of iron-oxide-based magnetic resonance contrast agents. , 1994, Investigative radiology.